[2026] Participation in the Spring Conference of the Korean Society of Clinical Chemistry

Bredis Healthcare participated in the

“2026 Spring Academic Conference of the Korean Society of Clinical Chemistry,” held on May 13–14, 2026, at the Gwanggaeto Hall Convention Hall at Sejong University in Seoul.

This marked our meaningful first meeting with the Korean Society of Clinical Chemistry.

With our full-scale entry into the diagnostics sector now confirmed,

we took this opportunity to introduce ourselves as a partner committed to the future development of the clinical chemistry field.

True to the conference theme, “Beyond AI to AI Agents,” featured in-depth discussions on the adoption of AI in laboratories and workflow optimization.

We also operated a promotional booth at the event, where we introduced our ultra-high-sensitivity analysis platform, SIMOA, and our neurology-specific biomarker analysis service based on NULISA technology.

It was a truly meaningful experience, thanks to the many attendees who showed professional interest in our precision analysis technology and responded positively to our presentation.

We have also prepared a “Roulette Event” at our booth to engage more actively with our visitors.

In addition to our analytical services, we offered prizes from Bredis Healthcare’s diverse lineup, including our wearable device “Cheetah Ring” and our health supplement “Cheetah Labs,” which received an enthusiastic response.

Thanks to this, we were able to introduce our product range in a friendly manner to many people and strengthen our connection with them.

Starting with this pleasant first meeting with the Korean Society of Clinical Chemistry, Bredis Healthcare plans to continue introducing innovative products and services to researchers in the diagnostic field.

We will never forget the enthusiastic interest shown at the event and will continue to grow and improve.

We ask for your continued interest and support for Bredis Healthcare’s future endeavors!